Klingelhoeffer, Christoph and Zeman, Florian and Meier, Johannes and Reichert, Torsten Eugen and Ettl, Tobias (2016) Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 44 (10). pp. 1694-1699. ISSN 1010-5182, 1878-4119
Full text not available from this repository. (Request a copy)Abstract
Purpose: Surgical treatment of the medication-related osteonecrosis of the jaw (MRONJ) is still challenging. We examined the outcome of the resection of osteonecrotic lesions and the influence of potential risk factors on the operative success. Methods: Seventy six surgical interventions on 40 patients were evaluated in a prospective design with a mean follow-up of 55 weeks. Primary endpoints were: (i) maintenance of the mucosal closure and (ii) decrease of MRONJ stage. Influential variables included preoperative duration, location and diameter of MRONJ, duration and change of antiresorptive therapy, presence of actinomyces species. Results: Only in 27.6% of cases long-term maintenance of the mucosal closure was achieved. However, stage II patients decreased to stage I in 81% after surgery (p < 0.01) and stage III patients improved in 83% of cases (OR = 8.08; p = 0.07). Stage I patients profited only in 38% by surgical intervention. MRONJ recurrence after surgery was associated with extended preoperative MRONJ duration (p = 0.015). There was no significance of further influential variables, but MRONJ of the upper jaw seems prognostically more favorable. Conclusion: Advanced stages of MRONJ benefit from surgical treatment, whereas stage I diseases may also be treated conservatively. An early intervention reduces the risk of recurrence. (C) 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; CANCER-PATIENTS; INFECTED OSTEORADIONECROSIS; BONE METASTASES; BREAST-CANCER; MANAGEMENT; DENOSUMAB; PREVALENCE; RESECTION; Bisphosphonates; Denosumab; Osteonecrosis; Surgery; Recurrence |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Mund-, Kiefer- und Gesichtschirurgie Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Klinische Studien |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 24 Apr 2019 11:47 |
| Last Modified: | 24 Apr 2019 11:47 |
| URI: | https://pred.uni-regensburg.de/id/eprint/4132 |
Actions (login required)
 |
View Item |
